Dongqing Lv Selected Research

Dongqing Lv Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2019
16	Neoplasms (Cancer) 01/2024 - 01/2020
6	Disease Progression 01/2024 - 01/2021
5	COVID-19 07/2021 - 01/2020
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2022
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
2	Pneumonia (Pneumonitis) 12/2022 - 04/2020
2	Adenocarcinoma of Lung 01/2022 - 08/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 03/2020
1	Reperfusion Injury 01/2024
1	Adenocarcinoma 01/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024
1	Ketosis 01/2023
1	Diabetes Mellitus 01/2023
1	Keratoacanthoma 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Exanthema (Rash) 01/2022
1	Diarrhea 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021
1	Cytokine Release Syndrome 07/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hemorrhage 01/2021
1	Pulmonary Hypertension 01/2021
1	Infections 01/2021
1	Pericardial Effusion 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 01/2024 - 08/2017
6	Tyrosine Kinase InhibitorsIBA 01/2024 - 08/2017
4	Gefitinib (Iressa)FDA Link 01/2024 - 01/2021
4	AfatinibIBA 01/2022 - 01/2019
3	aflutinibIBA 01/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2021
2	icotinibIBA 10/2023 - 11/2022
2	toripalimabIBA 01/2023 - 01/2022
2	camrelizumabIBA 01/2022 - 01/2022
2	anlotinibIBA 01/2022 - 01/2022
2	pyrotinibIBA 01/2022 - 01/2022
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 03/2020
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	MicroRNAs (MicroRNA)IBA 01/2024
1	atezolizumabIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Immune Checkpoint InhibitorsIBA 12/2022
1	Phosphotransferases (Kinase)IBA 11/2022
1	entrectinibIBA 11/2022
1	larotrectinibIBA 11/2022
1	tyrosine receptor (receptor, tyrosine)IBA 11/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	aumolertinibIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 10/2021
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2021
1	Long Noncoding RNAIBA 10/2021
1	CytokinesIBA 07/2021
1	Interleukin-6 (Interleukin 6)IBA 07/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	bivalirudin (Angiomax)FDA Link 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	2-naphthylaminomethyl-gamma-aminobutyric acid (A 144)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Angiogenesis InhibitorsIBA 01/2021
1	Leucine-Rich Repeat ProteinsIBA 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2020
1	Lipoprotein(a)IBA 03/2020
1	endostar proteinIBA 03/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Ubiquitin-Specific ProteasesIBA 01/2020
1	Gold Colloid (Colloidal Gold)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020

Therapy/Procedure

14	Therapeutics 10/2023 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
1	Radiotherapy 11/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2021
1	Immunotherapy 01/2021
1	Treatment Delay 01/2021
1	Secondary Prevention 04/2020
1	Length of Stay 04/2020
1	Chemoradiotherapy 03/2020